Recognizing the evolution of clinical syndrome spectrum progression in individuals with single large-scale mitochondrial DNA deletion syndromes (SLSMDS)

Authors:

Abstract
No abstract available
All Related Versions
Funding Information
  • Larimar Therapeutics
  • Astellas Pharma US

This publication has 33 references indexed in Scilit: